Horizon Investments LLC Buys 4,828 Shares of McKesson Corporation $MCK

Horizon Investments LLC boosted its stake in shares of McKesson Corporation (NYSE:MCK) by 125.4% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 8,679 shares of the company’s stock after purchasing an additional 4,828 shares during the period. Horizon Investments LLC’s holdings in McKesson were worth $7,119,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of the stock. GGM Financials LLC purchased a new position in shares of McKesson during the 3rd quarter valued at about $25,000. State of Wyoming purchased a new stake in McKesson in the 2nd quarter worth approximately $29,000. Hopwood Financial Services Inc. purchased a new stake in McKesson in the 3rd quarter worth approximately $31,000. Board of the Pension Protection Fund bought a new stake in McKesson during the 4th quarter worth approximately $33,000. Finally, Vermillion & White Wealth Management Group LLC purchased a new position in McKesson during the third quarter valued at approximately $33,000. Institutional investors own 85.07% of the company’s stock.

McKesson Price Performance

Shares of MCK opened at $814.69 on Friday. The firm has a market cap of $99.79 billion, a P/E ratio of 23.43, a price-to-earnings-growth ratio of 1.18 and a beta of 0.35. McKesson Corporation has a 1 year low of $637.00 and a 1 year high of $999.00. The company has a 50 day simple moving average of $894.86 and a two-hundred day simple moving average of $859.80.

McKesson (NYSE:MCK) last issued its earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, topping analysts’ consensus estimates of $9.19 by $0.15. The firm had revenue of $106.16 billion during the quarter, compared to analyst estimates of $105.98 billion. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. McKesson’s revenue for the quarter was up 11.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, sell-side analysts anticipate that McKesson Corporation will post 39.02 earnings per share for the current year.

McKesson Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 1st. Shareholders of record on Monday, June 1st will be issued a dividend of $0.82 per share. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. The ex-dividend date of this dividend is Monday, June 1st. McKesson’s dividend payout ratio is 9.43%.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the stock. Mizuho upped their price target on shares of McKesson from $880.00 to $885.00 and gave the stock a “neutral” rating in a research report on Thursday, February 5th. Weiss Ratings downgraded shares of McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a research report on Thursday, February 5th. William Blair initiated coverage on shares of McKesson in a report on Tuesday. They issued an “outperform” rating for the company. Morgan Stanley reiterated an “overweight” rating and issued a $966.00 price target on shares of McKesson in a research note on Thursday, January 29th. Finally, Raymond James Financial set a $970.00 price target on McKesson in a report on Thursday, March 5th. Fourteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $972.27.

Insider Transactions at McKesson

In other news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the firm’s stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $955.00, for a total transaction of $313,240.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Leann B. Smith sold 190 shares of the business’s stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $945.00, for a total value of $179,550.00. Following the completion of the sale, the executive vice president owned 2,989 shares in the company, valued at $2,824,605. This represents a 5.98% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 3,592 shares of company stock worth $3,518,555. 0.08% of the stock is currently owned by company insiders.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.